UVA protection factor (UVA-PF) testing is a critical procedure for verifying the effectiveness of sunscreen and cosmetic products against long-wave ultraviolet radiation (320–400 nm) that causes photoaging, pigmentation, and long-term skin damage. This article provides a comprehensive technical overview of UVA protection factor determination, covering internationally recognized methods such as ISO 24442 (in vivo) and ISO 24443 (in vitro), sample requirements, test parameters, regulatory applications, and frequently asked questions for manufacturers seeking compliant product certification.
Technical Overview
Ultraviolet A (UVA) radiation spans the wavelength range of 320 nm to 400 nm and accounts for approximately 95% of the UV radiation reaching the Earth's surface. Unlike UVB, UVA penetrates deeply into the dermis, generating reactive oxygen species, degrading collagen and elastin fibers, and inducing immediate and persistent pigment darkening. Chronic UVA exposure is strongly associated with photoaging, hyperpigmentation, and an elevated risk of skin cancer. Because SPF (Sun Protection Factor) primarily reflects protection against erythemal UVB radiation, a separate metric—the UVA Protection Factor (UVA-PF)—is required to quantify and substantiate a product's defense against UVA.
UVA protection factor determination is a laboratory-based performance test conducted on human volunteers (in vivo) or on artificial substrates using spectrophotometric measurement (in vitro). The resulting UVA-PF value, together with parameters such as critical wavelength, directly supports label claims including the PA (Protection Grade of UVA) system used in Asia, the UVA seal ("UVA" in a circle) in the European Union, and the "Broad Spectrum" designation in the United States. Accredited third-party laboratories performing these tests operate in accordance with internationally harmonized standards, including ISO 24442, ISO 24443, and ISO 24444, as well as regional technical regulations such as the European Commission Recommendation on the efficacy of sunscreen products and China's Safety and Technical Standards for Cosmetics.
- UVA-PF (UVA Protection Factor): the ratio of the minimum UVA dose required to induce persistent pigment darkening on protected skin versus unprotected skin.
- Critical wavelength (λc): the wavelength below which 90% of the total spectral absorbance from 290 nm to 400 nm is achieved; a value of 370 nm or greater indicates broad-spectrum protection.
- PA grading: UVA-PF results are commonly translated into label grades—PA+ (UVA-PF 2–4), PA++ (4–8), PA+++ (8–16), and PA++++ (>16).
- EU efficacy criterion: UVA-PF must be at least one third of the labeled SPF, and critical wavelength must be at least 370 nm.
Testing Samples
Sunscreen Products
Dedicated sun care products are the primary category subject to UVA protection factor determination. This includes sunscreen lotions, creams, gels, milks, oils, sticks, and sprays with labeled SPF values. Products are tested in their finished, market-ready formulation, and the test batch must be representative of the commercial product in terms of formulation, packaging, and manufacturing process.
Multifunctional and Decorative Cosmetics
Daily-use cosmetics carrying UV protection claims—such as moisturizers, day creams, BB creams, CC creams, liquid foundations, primers, tinted sunscreens, and lip care products—are also subject to UVA-PF evaluation whenever a UVA protection claim (e.g., PA+, UVA seal, or broad spectrum) is declared on the label or in marketing materials.
Special Population Products
Sunscreens formulated for children and sensitive skin, as well as water-resistant and sweat-resistant formulations, undergo UVA protection factor determination, typically combined with water resistance testing to confirm that UVA-PF is maintained after immersion. After-sun products and self-tanning products are generally tested only when a protection claim is made.
Sample Submission Requirements
- Finished product samples in original packaging, typically a minimum of 8–10 units or 200–500 g/mL per test method.
- Batch numbers, manufacturing date, and full ingredient list (INCI) to support method development and regulatory dossier preparation.
- Labeled SPF value or a parallel SPF test result (ISO 24444), which is required for in vitro UVA-PF calculation and ratio-based claims.
Testing Items
Depending on the target market and label claim strategy, accredited third-party laboratories typically offer the following UVA-related test items for cosmetic products:
- In vivo UVA-PF (Persistent Pigment Darkening method): determination of the UVA protection factor on human skin, applicable for PA labeling in markets that require or accept in vivo substantiation.
- In vitro UVA-PF: spectrophotometric determination of UVA protection factor on PMMA (polymethyl methacrylate) plates, used for the EU UVA seal and broad-spectrum claims.
- Critical wavelength (λc): assessment of the breadth of spectral protection, required for the US FDA "Broad Spectrum" claim and the EU recommendation.
- UVA-PF/SPF ratio: verification that UVA protection is proportional to labeled SPF, required under the EU recommendation and reflected in star-rating systems.
- Boots Star Rating: a five-category ratio-based rating of UVA to UVB absorbance used in the UK retail market.
- Photostability assessment: comparison of UVA-PF and spectral absorbance before and after controlled UV irradiation to evaluate whether the formulation maintains protection under sun exposure.
- Water resistance verification: post-immersion UVA-PF measurement to substantiate water-resistant claims (retention of at least 50% of the labeled value).
- PA grade classification: conversion of the validated UVA-PF result into PA+, PA++, PA+++, or PA++++ labeling.
Testing Methods
In Vivo Method — Persistent Pigment Darkening (ISO 24442)
The in vivo determination of UVA-PF is performed according to ISO 24442, which is recognized by regulators in numerous markets and aligns with China's Safety and Technical Standards for Cosmetics and the Japanese JCIA measurement standard. The procedure is conducted under independent ethics committee approval and documented informed consent:
- A panel of eligible volunteers is recruited after medical screening and skin phototype assessment (typically Fitzpatrick types II–IV).
- The test product is applied at a standardized density of 2 mg/cm² to a defined area on the back; a reference sunscreen formulation is applied in parallel to verify test validity.
- After a defined waiting period (approximately 15–30 minutes) for film formation, test sites are exposed to graded doses of UVA radiation generated by a filtered xenon arc solar simulator that has been calibrated and qualified to exclude significant UVB output.
- The skin response—persistent pigment darkening—is visually evaluated within the validated observation window (between 2 and 24 hours after exposure, commonly at 2–4 hours), when the pigmentation response is stable.
- The UVA protection factor is calculated as the ratio of the minimal pigmenting dose on protected skin to the minimal pigmenting dose on unprotected skin, and the result is accepted only when statistical validity criteria defined in the standard (confidence interval limits) are met.
In Vitro Method — Spectrophotometric Measurement (ISO 24443)
The in vitro UVA protection factor is determined according to ISO 24443, the method accepted in the European Union for substantiating the UVA seal claim:
- The product is applied at 1.3 mg/cm² onto roughened PMMA plates, with the film prepared using standardized spreading techniques to achieve reproducible, uniform coverage.
- Before measurement, samples are pre-irradiated with a calibrated UVA source to account for photo-induced changes in the UV filter system (photostability correction).
- UV transmittance is measured spectrophotometrically across the 290–400 nm spectral range before and after irradiation, with the plate mounted on an integrating sphere–equipped spectrophotometer.
- The in vitro UVA-PF is calculated using an iterative mathematical procedure anchored to the labeled or measured SPF value obtained from the in vivo ISO 24444 method, ensuring correlation between in vitro predictions and biological performance.
- Critical wavelength is derived from the cumulative spectral absorbance curve, identifying the wavelength at which 90% of the total area under the 290–400 nm absorbance curve is reached.
Method Selection Considerations
The choice between in vivo and in vitro determination depends on the destination market and the specific claim. In vivo PPD data (ISO 24442) remain the reference for PA labeling in several Asian jurisdictions, while the in vitro method (ISO 24443) is broadly used for EU compliance and is increasingly accepted for regulatory dossiers and claim substantiation. Many manufacturers commission both methods in parallel, together with SPF (ISO 24444), to build a complete, globally portable sun protection data package. The US FDA broad-spectrum procedure is an in vitro critical wavelength test with an acceptance threshold of λc ≥ 370 nm.
Applications
UVA protection factor determination serves multiple purposes across the product lifecycle:
- Regulatory compliance and market access: generation of test reports required for product notification or registration in China, the European Union, Japan, ASEAN markets, and other jurisdictions where UV protection claims are regulated.
- Label claim substantiation: scientific documentation supporting PA grades, the EU UVA seal, "Broad Spectrum" claims, and Boots Star ratings, protecting brands from misleading-advertising enforcement.
- Formulation development: comparative evaluation of UV filter systems, boosters, and photostabilizers during R&D, enabling optimization of the UVA-PF/SPF ratio before product launch.
- Photostability and stability studies: verification that UVA protection is maintained after UV exposure, accelerated storage, and transport stress.
- Quality control: batch-to-batch consistency verification and post-launch monitoring for contract manufacturers and brand owners.
- E-commerce and retail platform compliance: provision of accredited third-party laboratory test reports to satisfy documentation checks on major online and offline retail channels.
FAQ
What is the difference between SPF and UVA-PF?
SPF (determined per ISO 24444) measures protection against UVB-induced skin reddening (sunburn), whereas UVA-PF measures protection against UVA-induced persistent pigment darkening and deep-skin damage. A high SPF product does not automatically provide strong UVA protection, which is why dedicated UVA-PF testing is necessary.
How is the PA grade on the label determined?
The PA grade is derived from the measured UVA-PF: PA+ corresponds to UVA-PF of 2 to less than 4, PA++ to 4 to less than 8, PA+++ to 8 to less than 16, and PA++++ to 16 or higher. The value must be substantiated by testing conducted under a recognized standard such as ISO 24442 or an accepted in vitro equivalent.
How long does UVA-PF testing take?
In vivo PPD testing typically requires several weeks, accounting for ethics approval, panel recruitment, screening, application, exposure, and statistical evaluation. In vitro UVA-PF testing is considerably faster, generally completed within one to two weeks, as it does not require human volunteers. Exact lead times should be confirmed with the accredited third-party laboratory, including the number of products and test items commissioned.
Can the in vitro method replace in vivo testing?
The in vitro method (ISO 24443) is accepted for the EU UVA seal and broad-spectrum substantiation in many markets, but it requires a valid in vivo SPF result as a calculation input. Some jurisdictions still require or prefer in vivo UVA-PF data for PA labeling. Manufacturers targeting multiple markets should confirm applicable requirements and, where necessary, commission both methods.
What sample information should be provided before testing?
Applicants should submit finished product samples in original packaging, along with the full ingredient list, batch information, labeled SPF, intended claims, and target markets. This information enables the laboratory to select the correct method, prepare a compliant test plan, and issue a report suitable for the intended regulatory use.